Last year at this time I had the opportunity, along with 40 other prostate cancer advocates, to tour the Dendreon manufacturing facility in New Jersey. At the time the company was weeks away from FDA approval of Provenge and construction of the expanded facilities were in full swing. As I wrote at the time, it was very, very impressive.
Just last week they were finally granted FDA approval to begin using the expanded capacity, increasing from twelve to forty-eight stations.
This is great news for many, many men throughout this country battling against the advanced stages of prostate cancer.
There are two other sites currently under construction, in Georgia and Southern California. Dendreon is pursuing approval for these two sites and hoping to bring them on line later this year.
A good day and great news for the PCa community!
….And finally…..Happy St. Patrick’s Day!!!!!!!!